Literature DB >> 8909119

Psychotropic drug prescription in rehabilitation. A survey in Hong Kong.

G S Ungvari1, A H Pang, H F Chiu, C K Wong, F C Lum.   

Abstract

Rational pharmacotherapy helping chronic psychiatric patients in the difficult process of reintegration into the community is an important prerequisite of successful rehabilitation. Results of a survey conducted at the opening of a rehabilitation facility in Hong Kong revealed a number of illogicalities in prescription patterns. Frequently encountered faulty treatment decisions incompatible with the recommendations of modern literature included polypharmacy, higher than necessary doses of anticholinergic antiparkinsonian agents and giving psychotropic drugs in inconveniently divided doses. With the newly emerging subspecialty of rehabilitation-community psychiatry in Hong Kong, it is expected that large numbers of chronically hospitalized patients will enter rehabilitation programmes. The present survey indicated that it is imperative to pay continued attention to their medication status.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8909119     DOI: 10.1007/bf00787922

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  25 in total

1.  The persistence of prescribing habits: a survey and follow-up of prescribing to chronic hospital in-patients.

Authors:  A F Clark; N L Holden
Journal:  Br J Psychiatry       Date:  1987-01       Impact factor: 9.319

2.  A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.

Authors:  K M Lin; R E Poland; I Nuccio; K Matsuda; N Hathuc; T P Su; P Fu
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

Review 3.  Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.

Authors:  R J Baldessarini; B M Cohen; M H Teicher
Journal:  Arch Gen Psychiatry       Date:  1988-01

4.  Antipsychotic drugs: is more worse? A meta-analysis of the published randomized control trials.

Authors:  P Bollini; S Pampallona; M J Orza; M E Adams; T C Chalmers
Journal:  Psychol Med       Date:  1994-05       Impact factor: 7.723

5.  Lower-dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients.

Authors:  R C Smith
Journal:  Arch Gen Psychiatry       Date:  1994-05

6.  A survey of prescribing psychotropic drugs in two psychiatric hospitals.

Authors:  K Michel; T Kolakowska
Journal:  Br J Psychiatry       Date:  1981-03       Impact factor: 9.319

7.  Pharmacotherapy of chronic hospitalized schizophrenics: prescription practices.

Authors:  W H Wilson; T A Ban; W Guy
Journal:  Neuropsychobiology       Date:  1985       Impact factor: 2.328

8.  A survey of prescribing of psychotropic drugs in a Birmingham psychiatric hospital.

Authors:  S Edwards; V Kumar
Journal:  Br J Psychiatry       Date:  1984-11       Impact factor: 9.319

9.  A double-blind dose-reduction trial of fluphenazine decanoate for chronic, unstable schizophrenic patients.

Authors:  L B Inderbitzin; R R Lewine; G Scheller-Gilkey; C D Swofford; G J Egan; B A Gloersen; B P Vidanagama; C Waternaux
Journal:  Am J Psychiatry       Date:  1994-12       Impact factor: 18.112

Review 10.  Antipsychotic medication: clinical guidelines for maintenance therapy.

Authors:  D A Johnson
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

View more
  2 in total

1.  High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies.

Authors:  Kang Sim; Hsin Chuan Su; Senta Fujii; Shu-Yu Yang; Mian-Yoon Chong; Gabor Ungvari; Tianmei Si; Yan Ling He; Eun Kee Chung; Yiong Huak Chan; Naotaka Shinfuku; Ee Heok Kua; Chay Hoon Tan; Norman Sartorius
Journal:  Br J Clin Pharmacol       Date:  2009-01       Impact factor: 4.335

2.  The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999.

Authors:  Gabor S Ungvari; Yiu Gar Chung; Yip Ka Chee; Ng Fung-Shing; Tang Wai Kwong; Helen F K Chiu
Journal:  Br J Clin Pharmacol       Date:  2002-10       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.